Colonic Crypt Changes during Adenoma Development in Familial Adenomatous Polyposis : Immunohistochemical Evidence for Expansion of the Crypt Base Cell Population

Por Boman, Bruce M., Walters, Rhonda, Fields, Jeremy Z., Kovatich, Albert J., Zhang, Tao, Isenberg, Gerald A., Goldstein, Scott D., Palazzo, Juan P.
Publicado em 2004

Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms

Por Peck, Amy R, Girondo, Melanie A, Liu, Chengbao, Kovatich, Albert J, Hooke, Jeffrey A, Shriver, Craig D, Hu, Hai, Mitchell, Edith P, Freydin, Boris, Hyslop, Terry, Chervoneva, Inna, Rui, Hallgeir
Publicado no Mod Pathol (2016)

Positive Association of Fibroadenomatoid Change with HER2-Negative Invasive Breast Cancer: A Co-Occurrence Study

Por Chen, Yaqin, Bekhash, Anthony, Kovatich, Albert J., Hooke, Jeffrey A., Liu, Jianfang, Kvecher, Leonid, Fantacone-Campbell, J. Leigh, Mitchell, Edith P., Rui, Hallgeir, Mural, Richard J., Shriver, Craig D., Hu, Hai
Publicado no PLoS One (2015)

Loss of FHIT Expression in Transitional Cell Carcinoma of the Urinary Bladder

Por Baffa, Raffaele, Gomella, Leonard G., Vecchione, Andrea, Bassi, Pierfrancesco, Mimori, Koshi, Sedor, John, Calviello, Coleen M., Gardiman, Marina, Minimo, Corrado, Strup, Stephen E., McCue, Peter A., Kovatich, Albert J., Pagano, Francesco, Huebner, Kay, Croce, Carlo M.
Publicado em 2000

Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment

Por Yang, Ning, Liu, Chengbao, Peck, Amy R, Girondo, Melanie A, Yanac, Alicia F, Tran, Thai H, Utama, Fransiscus E, Tanaka, Takemi, Freydin, Boris, Chervoneva, Inna, Hyslop, Terry, Kovatich, Albert J, Hooke, Jeffrey A, Shriver, Craig D, Rui, Hallgeir
Publicado em 2013

Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression

Por Sato, Takahiro, Tran, Thai H., Peck, Amy R., Girondo, Melanie A., Liu, Chengbao, Goodman, Chelain R., Neilson, Lynn M., Freydin, Boris, Chervoneva, Inna, Hyslop, Terry, Kovatich, Albert J., Hooke, Jeffrey A., Shriver, Craig D., Fuchs, Serge Y., Rui, Hallgeir
Publicado em 2013

Loss of Nuclear Localized and Tyrosine Phosphorylated Stat5 in Breast Cancer Predicts Poor Clinical Outcome and Increased Risk of Antiestrogen Therapy Failure

Por Peck, Amy R., Witkiewicz, Agnieszka K., Liu, Chengbao, Stringer, Ginger A., Klimowicz, Alexander C., Pequignot, Edward, Freydin, Boris, Tran, Thai H., Yang, Ning, Rosenberg, Anne L., Hooke, Jeffrey A., Kovatich, Albert J., Nevalainen, Marja T., Shriver, Craig D., Hyslop, Terry, Sauter, Guido, Rimm, David L., Magliocco, Anthony M., Rui, Hallgeir
Publicado em 2011

Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes

Por Peck, Amy R, Witkiewicz, Agnieszka K, Liu, Chengbao, Klimowicz, Alexander C, Stringer, Ginger A, Pequignot, Edward, Freydin, Boris, Yang, Ning, Ertel, Adam, Tran, Thai H, Girondo, Melanie A, Rosenberg, Anne L, Hooke, Jeffrey A, Kovatich, Albert J, Shriver, Craig D, Rimm, David L, Magliocco, Anthony M, Hyslop, Terry, Rui, Hallgeir
Publicado em 2012